Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21636598rdf:typepubmed:Citationlld:pubmed
pubmed-article:21636598lifeskim:mentionsumls-concept:C0024501lld:lifeskim
pubmed-article:21636598lifeskim:mentionsumls-concept:C0000956lld:lifeskim
pubmed-article:21636598lifeskim:mentionsumls-concept:C0031444lld:lifeskim
pubmed-article:21636598lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:21636598lifeskim:mentionsumls-concept:C1511726lld:lifeskim
pubmed-article:21636598lifeskim:mentionsumls-concept:C0002045lld:lifeskim
pubmed-article:21636598lifeskim:mentionsumls-concept:C0815172lld:lifeskim
pubmed-article:21636598lifeskim:mentionsumls-concept:C1708715lld:lifeskim
pubmed-article:21636598lifeskim:mentionsumls-concept:C2346689lld:lifeskim
pubmed-article:21636598pubmed:issue15lld:pubmed
pubmed-article:21636598pubmed:dateCreated2011-8-2lld:pubmed
pubmed-article:21636598pubmed:abstractTextPolymorphisms in CYP2C9 and VKORC1 influence patients' phenprocoumon (PHE) and acenocoumarol (ACE) dose requirements. To provide physicians with tools to estimate the patient's individual dose, we aimed to develop algorithms for PHE and ACE.lld:pubmed
pubmed-article:21636598pubmed:languageenglld:pubmed
pubmed-article:21636598pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21636598pubmed:citationSubsetIMlld:pubmed
pubmed-article:21636598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21636598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21636598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21636598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21636598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21636598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21636598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21636598pubmed:statusMEDLINElld:pubmed
pubmed-article:21636598pubmed:monthAuglld:pubmed
pubmed-article:21636598pubmed:issn1522-9645lld:pubmed
pubmed-article:21636598pubmed:authorpubmed-author:le...lld:pubmed
pubmed-article:21636598pubmed:authorpubmed-author:RosendaalFrit...lld:pubmed
pubmed-article:21636598pubmed:authorpubmed-author:WesselsJudith...lld:pubmed
pubmed-article:21636598pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:21636598pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:21636598pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:21636598pubmed:authorpubmed-author:Maitland-van...lld:pubmed
pubmed-article:21636598pubmed:authorpubmed-author:SchalekampTom...lld:pubmed
pubmed-article:21636598pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:21636598pubmed:authorpubmed-author:VerhoefTalith...lld:pubmed
pubmed-article:21636598pubmed:authorpubmed-author:EU-PACT...lld:pubmed
pubmed-article:21636598pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21636598pubmed:volume32lld:pubmed
pubmed-article:21636598pubmed:ownerNLMlld:pubmed
pubmed-article:21636598pubmed:authorsCompleteYlld:pubmed
pubmed-article:21636598pubmed:pagination1909-17lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:meshHeadingpubmed-meshheading:21636598...lld:pubmed
pubmed-article:21636598pubmed:year2011lld:pubmed
pubmed-article:21636598pubmed:articleTitleLoading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data.lld:pubmed
pubmed-article:21636598pubmed:affiliationStudy coordinating Centre, Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO Box 80 082, 3508 TB Utrecht, The Netherlands.lld:pubmed
pubmed-article:21636598pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21636598pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:21636598pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:21636598pubmed:publicationTypeValidation Studieslld:pubmed